Prospects of antigen-specific therapy in type 1 diabetes mellitus

Type 1 diabetes mellitus is commonly recognized as an autoimmune disease characterized by progressive destruction of pancreatic ?-beta-cells. Progress in diagnostics at preclinical stage is accompanied with active development of preventive measures. So far, there are no specific therapeutic agents a...

Full description

Bibliographic Details
Main Authors: Tatiana Vasil'evna Nikonova, Yulia Viktorovna Alekseeva
Format: Article
Language:English
Published: Endocrinology Research Centre 2012-12-01
Series:Сахарный диабет
Subjects:
Online Access:https://dia-endojournals.ru/dia/article/viewFile/5534/3332
id doaj-dcc7b58ce30f498f8bd52c9a5e94510c
record_format Article
spelling doaj-dcc7b58ce30f498f8bd52c9a5e94510c2021-06-02T21:12:29ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782012-12-01154283210.14341/2072-0351-55345492Prospects of antigen-specific therapy in type 1 diabetes mellitusTatiana Vasil'evna Nikonova0Yulia Viktorovna Alekseeva1Endocrinology Research CentreEndocrinology Research CentreType 1 diabetes mellitus is commonly recognized as an autoimmune disease characterized by progressive destruction of pancreatic ?-beta-cells. Progress in diagnostics at preclinical stage is accompanied with active development of preventive measures. So far, there are no specific therapeutic agents approved for clinical practice. However, ongoing large-scale studies have outlined some promising solutions, antigen-specific immunotherapy being one of them.https://dia-endojournals.ru/dia/article/viewFile/5534/3332gad65hsp60diamyddiapep277diabetes mellitus type 1vaccinationgad65hsp60insulindiamyddiapep277
collection DOAJ
language English
format Article
sources DOAJ
author Tatiana Vasil'evna Nikonova
Yulia Viktorovna Alekseeva
spellingShingle Tatiana Vasil'evna Nikonova
Yulia Viktorovna Alekseeva
Prospects of antigen-specific therapy in type 1 diabetes mellitus
Сахарный диабет
gad65
hsp60
diamyd
diapep277
diabetes mellitus type 1
vaccination
gad65
hsp60
insulin
diamyd
diapep277
author_facet Tatiana Vasil'evna Nikonova
Yulia Viktorovna Alekseeva
author_sort Tatiana Vasil'evna Nikonova
title Prospects of antigen-specific therapy in type 1 diabetes mellitus
title_short Prospects of antigen-specific therapy in type 1 diabetes mellitus
title_full Prospects of antigen-specific therapy in type 1 diabetes mellitus
title_fullStr Prospects of antigen-specific therapy in type 1 diabetes mellitus
title_full_unstemmed Prospects of antigen-specific therapy in type 1 diabetes mellitus
title_sort prospects of antigen-specific therapy in type 1 diabetes mellitus
publisher Endocrinology Research Centre
series Сахарный диабет
issn 2072-0351
2072-0378
publishDate 2012-12-01
description Type 1 diabetes mellitus is commonly recognized as an autoimmune disease characterized by progressive destruction of pancreatic ?-beta-cells. Progress in diagnostics at preclinical stage is accompanied with active development of preventive measures. So far, there are no specific therapeutic agents approved for clinical practice. However, ongoing large-scale studies have outlined some promising solutions, antigen-specific immunotherapy being one of them.
topic gad65
hsp60
diamyd
diapep277
diabetes mellitus type 1
vaccination
gad65
hsp60
insulin
diamyd
diapep277
url https://dia-endojournals.ru/dia/article/viewFile/5534/3332
work_keys_str_mv AT tatianavasilevnanikonova prospectsofantigenspecifictherapyintype1diabetesmellitus
AT yuliaviktorovnaalekseeva prospectsofantigenspecifictherapyintype1diabetesmellitus
_version_ 1721400750110670848